Put this in your
pipe and smoke it: A University of Massachusetts
professor says the medical marijuana grown by the federal
government isn't very good. He wants a permit to
cultivate his own pot, saying it will be better for
research.
Lyle Craker, a
horticulturist who heads the school's medicinal plant
program, is challenging the government's 36-year-old
monopoly on research marijuana. Craker's suit claims
government-grown marijuana lacks the potency medical
researchers need to make important breakthroughs.
"The government's
marijuana just isn't strong enough," said Richard
Doblin, a Craker supporter who heads the Massachusetts-based
Multidisciplinary Association for Psychedelic Studies.
Many HIV patients
smoke or ingest marijuana to relieve the symptoms of
HIV and the adverse side effects of the antiretroviral drugs
used to treat it. Many researchers say marijuana plays
a key role in helping HIV-positive people avoid
AIDS-related wasting by combating the nausea that
often prevents them from eating. Cancer, multiple sclerosis,
and glaucoma patients also commonly use medical
marijuana to relieve disease symptoms or the adverse
side effects of treatment.
Eleven
states--Alaska, Arizona, California, Colorado, Hawaii,
Maine, Montana, Nevada, Oregon, Vermont, and
Washington--currently have laws permitting
medical marijuana use. The federal government, however,
continues to ban all uses of the drug, and the U.S. Supreme
Court has ruled in favor of the federal ban.
A hearing in
Craker's case got under way Monday before a federal
administrative judge at the Drug Enforcement Administration
and is expected to last all week. Craker's suit also
alleges there isn't enough of the drug freely
available for scientists across the country to work
with.
The DEA contends
that permitting other marijuana growers would lead to
greater illegal use of the drug. They have also said that
international treaties limit the United States to one
marijuana production facility.
A lab at the
University of Mississippi is the government's only
marijuana-growing facility.
DEA attorneys
defended the government's marijuana, contending its
Mississippi growing center provides adequate quality and
quantity for legitimate researchers across the
country.
"Whatever
material is needed could be provided under [the] process
that is already in place," said Mahmoud ElSohly, a research
professor who runs the cultivation program at the
school for government agencies, including a
1,200-square-foot "growing room."
The government's
official stockpile at the facility is about a metric
ton, he estimated. "We have quite a bit of inventory,"
ElSohly said. Most of it is stored in bulk in barrels
lined with federally approved plastic bags.
The most powerful
marijuana is stored in a walk-in freezer, part of the
facility's storage vault, to maintain its potency.
Craker, who has
been fighting the government for four years, did not
attend the hearing. Doblin, whose group hopes to fund
Craker's marijuana growing, said they have confidence
in their case, which has the support of nearly 40
members of Congress, including Massachusetts senators John
Kerry and Edward Kennedy.
"How do you
defend the government's case against the public interest
that there needs to be more research?" said Doblin, whose
group aims to expand medical research on psychedelic
drugs, including MDMA, also known as ecstasy. Doblin
said he believes there is great promise in the use of
"vaporized" marijuana as a health aid.
There was a
moment of levity in the DEA hearing room when ElSohly was
explaining how the marijuana is sometimes rolled into
cigarette form, asking the judge if she understood
what he meant. "I have no idea," replied DEA
administrative law judge Mary Ellen Bittner with a
smile.
Both sides expect
that a decision in the case is months away. (AP, with
additional reporting by Advocate.com)